Jun 2026 (Q2 FY26) — Sep 2, 2026
Zepp Health Q2 FY26 — Revenue Growth Returns with Improved Product Mix and Gross Margin
Read the full callZepp Health (ZEPP) earnings
- Jun 2026 (Q2 FY26)
- Dec 2025
Zepp Health earnings: last reported Wed, 2 Sep 2026, for the quarter ended Jun 2026.
Price
$2.92 −3.31% · −$0.1
Performance −94.3% 1Y
1Y: $51.44 on 17 Oct 2025 → $2.92. High $51.44 (17 Oct 2025), low $2.92 (19 Oct 2026).
- Previous close
- $3.02
- 52-week range
- $2.92 – $49.83
- One year
- −94.14%
Overview
- Symbol
- ZEPP
- Sector
- Information Technology
- Industry
- Electronic Computers
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — Jun 9, 2026
Zepp Health Q1 FY26 — Amazfit revenue +33.8% YoY with premiumization-led gross margin expansion
Read the full callEvery analysed call
Zepp Health earnings calls (ZEPP)
Financials
What the filings say
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | 49 | 131 | 174 | 199 | 137 | 104 | 29 | -11 |
| Total liabilities | 211 | 385 | 486 | 495 | 374 | 283 | 276 | 350 |
| Fixed assets | 6 | 9 | 19 | 21 | 15 | 9 | 7 | 6 |
| Investments | 7 | 2 | 3 | 3 | 5 | 5 | 1 | — |
| Total assets | 474 | 743 | 905 | 955 | 764 | 636 | 529 | 565 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 103 | 61 | 24 | -36 | -117 | 43 | -24 | -26 |
| Cash from investing | -47 | -16 | -32 | -168 | -6 | 8 | -2 | 1 |
| Cash from financing | 93 | 4 | 87 | 86 | 42 | -42 | 0 | 25 |
| Capital expenditure | -2 | -5 | -13 | -7 | -1 | -2 | -1 | -1 |
| Free cash flow | 100 | 57 | 11 | -44 | -118 | 41 | -26 | -26 |
Insider filings
5 filings between Jun 26, 2026 and Sep 24, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$87.5K
3 sales by 2 insiders
Compensation
not trading decisions- 2
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Deng Cheng | — | $45.3K | Jun 26, 2026 |
| Yu Pengtao | — | $42.1K | Sep 24, 2026 |
Latest filings (5)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Yu Pengtao Chief Industrial Designer | Sale | 4,251 | $17.4K |
| Sep 23, 2026 | Yu Pengtao Chief Industrial Designer | Sale | 5,749 | $24.7K |
| Jun 26, 2026 | FAN Meihui Chief Technology Officer | Option exercise | 520,000 | $0 |
| Jun 26, 2026 | Deng Cheng Chief Financial Officer | Option exercise | 22,875 | $0 |
| Jun 26, 2026 | Deng Cheng Chief Financial Officer | Sale | 9,836 | $45.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Zepp Health Corp
Free account. Everything above stays public.
Write why you follow Zepp Health Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading